These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28331673)

  • 1. The Outcome of Patients with Triple Negative Breast Cancer: The Turkish Oncology Group Experience.
    Eralp Y; Kılıç L; Alço G; Başaran G; Doğan M; Dinçol D; Demirci S; İçli F; Onur H; Saip P; Haydaroğlu A
    J Breast Health; 2014 Oct; 10(4):209-215. PubMed ID: 28331673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic analysis of triple-negative breast cancer patients treated with adjuvant chemotherapy of fluorouracil, epirubicin and cyclophosphamide.
    Sun W; Li C; Liu M; Liu W; Yang C; Cai LI
    Oncol Lett; 2016 Mar; 11(3):2320-2326. PubMed ID: 26998170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of 561 non-metastatic triple negative breast cancer patients: multi-center experience from Turkey.
    Budakoglu B; Altundag K; Aksoy S; Kaplan MA; Ozdemir NY; Berk V; Ozkan M; Algin E; Kandemir N; Dogu GG; Harputluoglu H; Arslan UY; Coskun U; Isikdogan A; Oksuzoglu B
    J BUON; 2014; 19(4):872-8. PubMed ID: 25536589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of type 2 diabetes mellitus on the prognosis of early stage triple-negative breast cancer in People's Republic of China.
    Ma FJ; Liu ZB; Qu L; Hao S; Liu GY; Wu J; Shao ZM
    Onco Targets Ther; 2014; 7():2147-54. PubMed ID: 25473296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stratification of Prognosis of Triple-Negative Breast Cancer Patients Using Combinatorial Biomarkers.
    Yue Y; Astvatsaturyan K; Cui X; Zhang X; Fraass B; Bose S
    PLoS One; 2016; 11(3):e0149661. PubMed ID: 26930401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Clinical and Treatment Factors on Survival Outcomes of Triple Negative Breast Cancer Patients.
    Wen S; Manuel L; Doolan M; Westhuyzen J; Shakespeare TP; Aherne NJ
    Breast Cancer (Dove Med Press); 2020; 12():27-35. PubMed ID: 32184654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the prognostic factors, survival, and recurrence incidence of triple negative breast cancer patients, a single center study in Iran.
    Mousavi SA; Kasaeian A; Pourkasmaee M; Ghavamzadeh A; Alimoghaddam K; Vaezi M; Kamranzadeh Fumani H; Babakhani D; Tavakoli S
    PLoS One; 2019; 14(1):e0208701. PubMed ID: 30608935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy in pT1ab node-negative triple-negative breast carcinomas: Results of a national multi-institutional retrospective study.
    de Nonneville A; Gonçalves A; Zemmour C; Cohen M; Classe JM; Reyal F; Colombo PE; Jouve E; Giard S; Barranger E; Sabatier R; Bertucci F; Boher JM; Houvenaeghel G
    Eur J Cancer; 2017 Oct; 84():34-43. PubMed ID: 28780480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapy.
    Park JH; Jonas SF; Bataillon G; Criscitiello C; Salgado R; Loi S; Viale G; Lee HJ; Dieci MV; Kim SB; Vincent-Salomon A; Curigliano G; André F; Michiels S
    Ann Oncol; 2019 Dec; 30(12):1941-1949. PubMed ID: 31566659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic factors of lymph node-negative metastasis gastric cancer].
    Sun D; Xu H; Huang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Clinical Features and Outcome of 356 Triple-Negative Breast Cancer Patients in China.
    Zhang L; Hao C; Dong G; Tong Z
    Breast Care (Basel); 2012 Feb; 7(1):13-17. PubMed ID: 22553467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expressions of NEDD9 and E-cadherin correlate with metastasis and poor prognosis in triple-negative breast cancer patients.
    Li P; Sun T; Yuan Q; Pan G; Zhang J; Sun D
    Onco Targets Ther; 2016; 9():5751-5759. PubMed ID: 27703373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological and Prognostic Characteristics of Malaysian Triple Negative Breast Cancer Patients Undergoing TAC Chemotherapy Regimen.
    Abdul Aziz AA; Md Salleh MS; Ankathil R
    Int J Breast Cancer; 2020; 2020():8424365. PubMed ID: 32308997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors affecting disease-free survival in patients at age 35 or younger with invasive breast cancer.
    Koca B; Kuru B; Karabicak I; Yürüker SS; Ozen N
    Ann Ital Chir; 2014; 85(3):249-53. PubMed ID: 25074433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lobular invasive breast cancer prognostic factors: About 940 patients].
    Jauffret C; Houvenaeghel G; Classe JM; Garbay JR; Giard S; Charitansky H; Cohen M; Bélichard C; Faure C; Darai É; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Coutant C; Dravet F; Chauvet MP; Chéreau Ewald E; Penault-Llorca F; Goncalves A; Lambaudie É
    Gynecol Obstet Fertil; 2015 Nov; 43(11):712-7. PubMed ID: 26482833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor Size Still Impacts Prognosis in Breast Cancer With Extensive Nodal Involvement.
    Liu Y; He M; Zuo WJ; Hao S; Wang ZH; Shao ZM
    Front Oncol; 2021; 11():585613. PubMed ID: 33898305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progesterone Receptors, Pathological Complete Response and Early Outcome for Locally Advanced Breast Cancer - a Single Centre Study. (PPLB - 01).
    Agrawal S; Banswal L; Saha A; Arun I; Datta SS; Chatterjee S; Ahmed R
    Indian J Surg Oncol; 2016 Dec; 7(4):397-406. PubMed ID: 27872526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metaplastic Carcinoma of the Breast Is More Aggressive Than Triple-negative Breast Cancer: A Study From a Single Institution and Review of Literature.
    El Zein D; Hughes M; Kumar S; Peng X; Oyasiji T; Jabbour H; Khoury T
    Clin Breast Cancer; 2017 Aug; 17(5):382-391. PubMed ID: 28529029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients.
    Karatas F; Erdem GU; Sahin S; Aytekin A; Yuce D; Sever AR; Babacan T; Ates O; Ozisik Y; Altundag K
    Breast; 2017 Apr; 32():237-244. PubMed ID: 27318645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple negative breast cancer - prognostic factors and survival.
    Ovcaricek T; Frkovic SG; Matos E; Mozina B; Borstnar S
    Radiol Oncol; 2011 Mar; 45(1):46-52. PubMed ID: 22933934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.